Your browser doesn't support javascript.
loading
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM).
Janning, M; Süptitz, J; Albers-Leischner, C; Delpy, P; Tufman, A; Velthaus-Rusik, J-L; Reck, M; Jung, A; Kauffmann-Guerrero, D; Bonzheim, I; Brändlein, S; Hummel, H-D; Wiesweg, M; Schildhaus, H-U; Stratmann, J A; Sebastian, M; Alt, J; Buth, J; Esposito, I; Berger, J; Tögel, L; Saalfeld, F C; Wermke, M; Merkelbach-Bruse, S; Hillmer, A M; Klauschen, F; Bokemeyer, C; Buettner, R; Wolf, J; Loges, S.
Afiliación
  • Janning M; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, Univers
  • Süptitz J; Department of Internal Medicine I, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Albers-Leischner C; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Delpy P; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany; Federated Information Systems, German Cancer Research Center (DKFZ), Heidelberg, Germany; Complex Data Processing in Medical Informatics, University Medical Centre Mannheim, Mannheim, Germany.
  • Tufman A; Department of Internal Medicine V, University of Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich, Germany.
  • Velthaus-Rusik JL; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Reck M; LungenClinic Grosshansdorf, Thoracic Oncology, Airway Research Center North, German Center of Lung Research, Grosshansdorf, Germany.
  • Jung A; Pathology Institute, Ludwig Maximilians University of Munich, Munich, Germany; German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kauffmann-Guerrero D; Department of Internal Medicine V, University of Munich, Comprehensive Pneumology Center, Member of the German Center for Lung Research, Munich, Germany.
  • Bonzheim I; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen and Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany.
  • Brändlein S; Institute of Pathology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany.
  • Hummel HD; Translational Oncology/Early Clinical Trial Unit (ECTU), Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
  • Wiesweg M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Schildhaus HU; Institute of Pathology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
  • Stratmann JA; Department of Internal Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany.
  • Sebastian M; Department of Internal Medicine, Hematology/Oncology, Goethe University, Frankfurt, Germany.
  • Alt J; Department of Hematology, Medical Oncology & Pneumology, University Medical Center Mainz, Mainz, Germany.
  • Buth J; Institute of Pathology, Heinrich Heine University and University Hospital of Duesseldorf, Duesseldorf, Germany.
  • Esposito I; Institute of Pathology, Heinrich Heine University and University Hospital of Duesseldorf, Duesseldorf, Germany.
  • Berger J; Charité Comprehensive Cancer Center, Berlin, Germany.
  • Tögel L; Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen, Germany.
  • Saalfeld FC; Clinic for Internal Medicine I, University Hospital, TU Dresden, Dresden, Germany.
  • Wermke M; Clinic for Internal Medicine I, University Hospital, TU Dresden, Dresden, Germany.
  • Merkelbach-Bruse S; Institute of Pathology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Hillmer AM; Institute of Pathology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.
  • Klauschen F; Pathology Institute, Ludwig Maximilians University of Munich, Munich, Germany; German Cancer Consortium (DKTK), partner site Munich and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bokemeyer C; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Comprehensive Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Buettner R; Institute of Pathology, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Wolf J; Department of Internal Medicine I, Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany.
  • Loges S; DKFZ-Hector Cancer Institute at the University Medical Center Mannheim, Mannheim, Germany; Division of Personalized Medical Oncology (A420), German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Personalized Oncology, University Hospital Mannheim, Medical Faculty Mannheim, Univers
Ann Oncol ; 33(6): 602-615, 2022 06.
Article en En | MEDLINE | ID: mdl-35263633

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article